Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (373)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
35
2026
2324
4.960
Why?
Machine Learning
8
2025
587
2.230
Why?
Stroke Volume
17
2025
650
1.880
Why?
Adrenergic beta-Antagonists
10
2025
251
1.530
Why?
Methadone
5
2023
122
1.420
Why?
Pregnancy Complications, Cardiovascular
5
2022
83
1.420
Why?
Buprenorphine
3
2023
190
1.310
Why?
Cardiomyopathies
5
2022
334
1.310
Why?
United States Food and Drug Administration
5
2024
205
1.200
Why?
Decision Support Systems, Clinical
6
2024
269
1.150
Why?
Cardiomyopathy, Dilated
9
2025
355
1.110
Why?
Pharmacogenetics
5
2024
172
1.110
Why?
Adverse Drug Reaction Reporting Systems
4
2024
81
1.080
Why?
Arrhythmias, Cardiac
6
2023
355
1.040
Why?
Cytochrome P-450 CYP2C19
4
2024
26
0.960
Why?
Electronic Health Records
7
2024
1176
0.950
Why?
Propanolamines
3
2019
40
0.890
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
438
0.860
Why?
Hospitalization
10
2024
2446
0.840
Why?
Workflow
2
2026
182
0.830
Why?
Telemedicine
4
2024
957
0.740
Why?
Atrial Fibrillation
5
2026
555
0.730
Why?
Torsades de Pointes
4
2016
23
0.710
Why?
Seasons
1
2024
556
0.700
Why?
Pulmonary Edema
1
2021
105
0.690
Why?
Humans
88
2026
144667
0.680
Why?
Coffee
1
2021
15
0.670
Why?
Pharmacogenomic Testing
4
2022
62
0.640
Why?
Stroke
2
2021
1262
0.630
Why?
Platelet Aggregation Inhibitors
1
2024
496
0.620
Why?
Aged
33
2026
25955
0.610
Why?
Defibrillators, Implantable
2
2021
381
0.600
Why?
Artificial Intelligence
2
2026
381
0.590
Why?
Prosthesis Failure
1
2020
125
0.590
Why?
Prosthesis-Related Infections
1
2020
98
0.580
Why?
Long QT Syndrome
3
2016
69
0.570
Why?
Mobile Applications
1
2021
197
0.570
Why?
Spironolactone
1
2019
39
0.570
Why?
Device Removal
1
2020
142
0.570
Why?
United States
22
2025
16018
0.560
Why?
Pacemaker, Artificial
1
2020
126
0.560
Why?
Risk Assessment
10
2026
3729
0.560
Why?
Medical Records
2
2019
191
0.550
Why?
Coronary Disease
1
2021
381
0.550
Why?
Mineralocorticoid Receptor Antagonists
1
2019
68
0.550
Why?
Diabetes Mellitus
2
2024
1076
0.540
Why?
Biomedical Research
2
2024
712
0.540
Why?
Periodicals as Topic
1
2020
206
0.530
Why?
Mortality
3
2019
377
0.520
Why?
Retrospective Studies
22
2026
17149
0.520
Why?
Hypertension, Pregnancy-Induced
1
2018
67
0.500
Why?
Female
50
2026
78304
0.500
Why?
Receptors, Transforming Growth Factor beta
1
2017
55
0.500
Why?
Hospital Records
1
2016
10
0.490
Why?
Proteoglycans
1
2017
110
0.480
Why?
Ventricular Function, Left
5
2025
536
0.480
Why?
Analgesics, Opioid
2
2023
1142
0.470
Why?
Hospital Mortality
6
2024
1033
0.470
Why?
Disease Management
1
2020
650
0.450
Why?
Survival
1
2015
38
0.450
Why?
Tetrazoles
1
2015
49
0.450
Why?
Male
42
2026
72431
0.450
Why?
Middle Aged
30
2025
35971
0.440
Why?
Electrocardiography
5
2026
664
0.440
Why?
Biphenyl Compounds
1
2015
66
0.440
Why?
Muscle Proteins
2
2025
240
0.430
Why?
Myocardial Infarction
3
2018
1209
0.420
Why?
Research Design
1
2020
1129
0.410
Why?
Ventricular Remodeling
3
2025
275
0.400
Why?
Loperamide
2
2023
12
0.400
Why?
Myocardium
3
2017
928
0.390
Why?
Polymorphism, Single Nucleotide
4
2017
2137
0.380
Why?
Diet
1
2021
1270
0.380
Why?
Tachycardia, Ventricular
1
2015
180
0.380
Why?
Registries
2
2020
2392
0.380
Why?
Precision Medicine
6
2024
454
0.370
Why?
Adult
28
2024
40489
0.370
Why?
Legislation, Medical
1
2012
11
0.370
Why?
Amiodarone
1
2012
31
0.360
Why?
Phenotype
5
2025
3147
0.360
Why?
Peripartum Period
4
2022
19
0.360
Why?
Patient Readmission
1
2018
765
0.350
Why?
Quality Improvement
2
2020
1287
0.350
Why?
Anti-Arrhythmia Agents
1
2012
141
0.340
Why?
Sex Factors
4
2024
2104
0.330
Why?
Pyrazines
2
2008
92
0.330
Why?
Heart Arrest
4
2019
406
0.330
Why?
Catheter Ablation
1
2015
354
0.330
Why?
Cardiovascular Diseases
5
2024
2172
0.320
Why?
Treatment Outcome
10
2025
11735
0.320
Why?
Transfusion Reaction
1
2011
61
0.320
Why?
Forecasting
2
2024
391
0.320
Why?
Triazoles
2
2008
184
0.320
Why?
Heart-Assist Devices
1
2016
568
0.320
Why?
Echocardiography
3
2024
644
0.310
Why?
Risk Factors
10
2025
10796
0.310
Why?
Postoperative Complications
2
2020
2950
0.300
Why?
Insurance, Health
1
2012
308
0.300
Why?
Patient Discharge
2
2021
985
0.300
Why?
Patient Transfer
1
2012
208
0.290
Why?
Anemia
1
2011
189
0.290
Why?
Thiazolidinediones
1
2010
139
0.290
Why?
Databases, Factual
5
2020
1494
0.290
Why?
Genotype
3
2024
1847
0.290
Why?
Marketing
1
2008
23
0.290
Why?
Renal Insufficiency
1
2011
172
0.280
Why?
Rhabdomyolysis
1
2008
24
0.280
Why?
Drug Industry
1
2008
49
0.280
Why?
Aged, 80 and over
7
2024
8284
0.280
Why?
Simvastatin
1
2008
59
0.280
Why?
Heart Ventricles
4
2017
751
0.270
Why?
Receptors, Adrenergic, beta-1
4
2019
24
0.270
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.270
Why?
Incidence
6
2025
2892
0.270
Why?
Heart Rate
3
2025
853
0.270
Why?
Follow-Up Studies
7
2025
5414
0.260
Why?
Length of Stay
4
2024
1339
0.260
Why?
Cytochrome P-450 CYP2D6
3
2022
32
0.260
Why?
Kaplan-Meier Estimate
3
2016
967
0.260
Why?
Proportional Hazards Models
4
2021
1322
0.260
Why?
Pharmacovigilance
2
2024
23
0.250
Why?
Practice Patterns, Physicians'
3
2020
1360
0.250
Why?
Elective Surgical Procedures
2
2020
201
0.240
Why?
Biological Specimen Banks
3
2024
105
0.230
Why?
Atrial Flutter
1
2026
47
0.230
Why?
Gene Expression Regulation
1
2015
2591
0.230
Why?
Emergency Service, Hospital
2
2020
2325
0.220
Why?
Patient Reported Outcome Measures
2
2020
496
0.220
Why?
Cause of Death
2
2019
464
0.220
Why?
Glucose
1
2010
1033
0.210
Why?
New York
1
2024
127
0.210
Why?
Diabetic Cardiomyopathies
1
2024
34
0.210
Why?
Pandemics
3
2022
1700
0.210
Why?
Young Adult
9
2022
14122
0.200
Why?
Pregnancy
6
2022
7122
0.200
Why?
Diphenoxylate
1
2023
5
0.200
Why?
Acute Kidney Injury
2
2008
869
0.200
Why?
Adolescent
10
2020
22409
0.190
Why?
Randomized Controlled Trials as Topic
3
2021
1742
0.190
Why?
Nonprescription Drugs
1
2023
67
0.190
Why?
Monitoring, Physiologic
1
2024
288
0.190
Why?
Heart Defects, Congenital
2
2020
905
0.180
Why?
Prognosis
5
2020
4312
0.180
Why?
Algorithms
4
2025
1844
0.180
Why?
Medicare
2
2020
899
0.180
Why?
Naltrexone
1
2023
118
0.180
Why?
Insulin Resistance
1
2010
1241
0.170
Why?
Speech
1
2021
78
0.170
Why?
Hypertension
2
2020
1262
0.170
Why?
Red Meat
1
2021
17
0.170
Why?
Time Factors
3
2020
7140
0.170
Why?
Losartan
1
2020
13
0.160
Why?
Data Interpretation, Statistical
2
2020
368
0.160
Why?
Lisinopril
1
2020
15
0.160
Why?
Drug Dosage Calculations
1
2020
27
0.160
Why?
Smartphone
1
2021
100
0.160
Why?
Protective Factors
1
2021
99
0.160
Why?
Angioedema
1
2020
15
0.160
Why?
Actigraphy
1
2021
147
0.160
Why?
Cardiac Resynchronization Therapy
1
2021
63
0.160
Why?
Wearable Electronic Devices
1
2021
62
0.160
Why?
American Heart Association
2
2019
356
0.160
Why?
Milk
1
2021
119
0.160
Why?
Hypoglycemic Agents
1
2010
1388
0.160
Why?
Turner Syndrome
1
2021
64
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Indans
1
2020
13
0.150
Why?
Oxadiazoles
1
2020
37
0.150
Why?
Bionics
1
2019
14
0.150
Why?
Editorial Policies
1
2020
46
0.150
Why?
California
2
2012
471
0.150
Why?
Biological Products
1
2023
256
0.150
Why?
Medical Informatics
1
2020
96
0.150
Why?
Referral and Consultation
2
2017
852
0.150
Why?
Fingolimod Hydrochloride
1
2020
39
0.150
Why?
Medical Futility
1
2019
32
0.150
Why?
Software
2
2015
695
0.150
Why?
Medical Record Linkage
1
2020
68
0.150
Why?
Prescription Drugs
1
2020
109
0.150
Why?
Information Storage and Retrieval
1
2020
122
0.150
Why?
Drug Overdose
1
2023
371
0.140
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
82
0.140
Why?
Sitagliptin Phosphate
2
2008
31
0.140
Why?
Medical Order Entry Systems
1
2019
40
0.140
Why?
Drug Prescriptions
1
2021
283
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2019
0.140
Why?
Child Health Services
1
2020
185
0.140
Why?
Tobacco Use
1
2019
62
0.140
Why?
Cohort Studies
3
2021
5957
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Cluster Analysis
1
2019
516
0.140
Why?
Social Determinants of Health
1
2022
305
0.140
Why?
Receptors, Histamine H2
1
2017
6
0.130
Why?
Gene Regulatory Networks
2
2023
319
0.130
Why?
Florida
1
2018
117
0.130
Why?
Advisory Committees
1
2019
228
0.130
Why?
Neisseria gonorrhoeae
1
1997
29
0.130
Why?
Porins
1
1997
18
0.130
Why?
Dyslipidemias
1
2019
182
0.130
Why?
Consensus
1
2019
475
0.130
Why?
Prospective Studies
4
2021
7994
0.120
Why?
Nursing Assessment
1
2017
53
0.120
Why?
Academic Medical Centers
1
2020
545
0.120
Why?
Pressure Ulcer
1
2017
40
0.120
Why?
Patient Participation
1
2020
428
0.120
Why?
Heart Diseases
1
2020
341
0.120
Why?
Population Surveillance
1
2020
484
0.120
Why?
Antihypertensive Agents
1
2020
512
0.120
Why?
Hospitals, Teaching
1
2017
119
0.120
Why?
Tilidine
1
2016
2
0.120
Why?
Cardiology
1
2019
359
0.120
Why?
Genetic Markers
1
2017
332
0.120
Why?
Double-Blind Method
3
2025
2033
0.120
Why?
Oxycodone
1
2016
53
0.110
Why?
Rheumatic Fever
1
2015
5
0.110
Why?
Rheumatic Heart Disease
1
2015
4
0.110
Why?
Databases, Genetic
1
2017
247
0.110
Why?
Sex Distribution
1
2016
386
0.110
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.110
Why?
Cholesterol Ester Transfer Proteins
1
2015
22
0.110
Why?
Angiotensin II
1
2015
95
0.110
Why?
Hospitals, Low-Volume
1
2015
26
0.110
Why?
Gene Expression Profiling
3
2017
1766
0.110
Why?
Immunosuppressive Agents
1
2020
834
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
751
0.110
Why?
Computational Biology
2
2017
681
0.110
Why?
Naloxone
1
2016
131
0.110
Why?
Hospitals, High-Volume
1
2015
50
0.110
Why?
Marijuana Use
1
2018
212
0.110
Why?
Mothers
1
2020
765
0.110
Why?
United Kingdom
1
2015
337
0.100
Why?
Percutaneous Coronary Intervention
1
2020
547
0.100
Why?
Biomarkers
2
2024
4261
0.100
Why?
Age Factors
2
2019
3329
0.100
Why?
International Classification of Diseases
1
2015
147
0.100
Why?
Comorbidity
1
2019
1652
0.100
Why?
Chronic Disease
2
2020
1810
0.100
Why?
Gene Expression
2
2017
1476
0.100
Why?
Down-Regulation
1
2015
616
0.100
Why?
MicroRNAs
2
2017
689
0.100
Why?
Narcotic Antagonists
1
2015
204
0.100
Why?
Cholesterol
1
2015
404
0.100
Why?
Ventricular Dysfunction, Left
2
2020
392
0.100
Why?
Federal Government
1
2012
23
0.090
Why?
Coronary Artery Disease
1
2019
743
0.090
Why?
Myocytes, Cardiac
1
2017
538
0.090
Why?
Drug Resistance
1
2012
145
0.090
Why?
RNA, Messenger
2
2017
2815
0.090
Why?
Area Under Curve
1
2012
329
0.090
Why?
Genetic Predisposition to Disease
2
2017
2350
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
919
0.080
Why?
Colorado
4
2024
4558
0.080
Why?
Predictive Value of Tests
1
2017
2117
0.080
Why?
Patient Safety
1
2015
353
0.080
Why?
Gastrointestinal Hemorrhage
1
2012
136
0.080
Why?
Anti-Retroviral Agents
1
2013
250
0.080
Why?
Opiate Substitution Treatment
1
2013
186
0.080
Why?
Bayes Theorem
1
2012
426
0.080
Why?
Managed Care Programs
2
2022
140
0.080
Why?
Survival Rate
1
2015
2089
0.080
Why?
Pregnancy Outcome
1
2013
479
0.080
Why?
Genome-Wide Association Study
1
2017
1374
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
237
0.080
Why?
Delivery of Health Care
1
2017
944
0.080
Why?
Multivariate Analysis
1
2012
1537
0.070
Why?
Severity of Illness Index
1
2017
2922
0.070
Why?
Pharmacogenomic Variants
2
2019
33
0.070
Why?
Primary Health Care
1
2019
1730
0.070
Why?
Drug Approval
1
2008
91
0.070
Why?
Emergency Medical Services
1
2015
695
0.070
Why?
Vasodilator Agents
1
2010
329
0.070
Why?
Logistic Models
1
2012
2114
0.060
Why?
Kidney Function Tests
1
2007
156
0.060
Why?
Animals
3
2023
37948
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
259
0.060
Why?
Zimbabwe
2
2017
76
0.060
Why?
Drug Therapy, Combination
1
2008
1044
0.060
Why?
Reproducibility of Results
2
2026
3414
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.050
Why?
Models, Biological
1
2012
1811
0.050
Why?
Case-Control Studies
1
2012
3603
0.050
Why?
Opioid-Related Disorders
1
2013
601
0.050
Why?
Canada
1
2026
432
0.050
Why?
Psychological Tests
1
2005
132
0.050
Why?
Potassium Channels
1
2025
145
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
40
0.050
Why?
Mandible
1
2004
73
0.050
Why?
Depression
2
2022
1561
0.050
Why?
Cross-Sectional Studies
3
2022
5870
0.050
Why?
Receptors, Adrenergic
1
2023
20
0.050
Why?
Drug Administration Schedule
2
2020
779
0.050
Why?
Cardiovascular Agents
1
2025
165
0.050
Why?
Carcinoembryonic Antigen
1
2002
40
0.050
Why?
Antigens, Differentiation
1
2002
76
0.040
Why?
Child
5
2020
22600
0.040
Why?
Antigens, Bacterial
1
2002
127
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
178
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
11
0.040
Why?
Health Services Misuse
1
2020
35
0.040
Why?
Antigens, Neoplasm
1
2002
272
0.040
Why?
Insurance Claim Reporting
1
2020
26
0.040
Why?
Antidepressive Agents
1
2022
248
0.040
Why?
Lymphocyte Count
1
2020
164
0.040
Why?
Morbidity
1
2020
322
0.040
Why?
Metoprolol
1
2019
26
0.040
Why?
Membrane Glycoproteins
1
2002
496
0.040
Why?
Antineoplastic Agents
1
2010
2201
0.040
Why?
Grounded Theory
1
2019
45
0.040
Why?
Bias
1
2020
197
0.040
Why?
Aftercare
1
2020
222
0.040
Why?
Antigens, CD
1
2002
552
0.040
Why?
Genomics
1
2024
831
0.030
Why?
Mice, Transgenic
1
2023
2184
0.030
Why?
Coronary Angiography
1
2020
324
0.030
Why?
HIV Infections
1
2013
3148
0.030
Why?
Amino Acid Sequence
2
2002
2136
0.030
Why?
Delivery of Health Care, Integrated
1
2020
299
0.030
Why?
Static Electricity
1
1997
114
0.030
Why?
Exercise Test
1
2020
626
0.030
Why?
Molecular Sequence Data
2
2002
2909
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
104
0.030
Why?
Inpatients
1
2021
547
0.030
Why?
Focus Groups
1
2019
566
0.030
Why?
Socioeconomic Factors
1
2020
1322
0.030
Why?
Frail Elderly
1
2017
135
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
339
0.030
Why?
World Health Organization
1
2016
104
0.030
Why?
Metabolic Networks and Pathways
1
2017
187
0.030
Why?
Puerperal Disorders
1
2016
37
0.030
Why?
Physician-Patient Relations
1
2020
589
0.030
Why?
Neoplasms
1
2010
2873
0.030
Why?
Decision Trees
1
2015
79
0.030
Why?
Drug Combinations
1
2016
393
0.030
Why?
Data Mining
1
2015
115
0.030
Why?
Blood Pressure
1
2020
1766
0.030
Why?
Cell Membrane
1
1997
706
0.020
Why?
Biopsy
1
2017
1079
0.020
Why?
Pediatrics
1
2020
1121
0.020
Why?
Models, Genetic
1
2015
531
0.020
Why?
Liver
1
2020
1889
0.020
Why?
Infant
2
2015
10023
0.020
Why?
Mass Screening
2
2013
1348
0.020
Why?
Anthracyclines
1
2010
49
0.020
Why?
Child, Preschool
2
2015
11790
0.020
Why?
Trastuzumab
1
2010
117
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
115
0.020
Why?
Signal Transduction
1
2023
5185
0.020
Why?
Clinical Trials as Topic
1
2015
1056
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
228
0.020
Why?
Program Evaluation
1
2013
941
0.020
Why?
Apoptosis
1
2017
2397
0.020
Why?
Injections, Intravenous
1
2007
198
0.020
Why?
Natriuretic Peptide, Brain
1
2007
109
0.020
Why?
Infusions, Intravenous
1
2007
422
0.020
Why?
Ultrasonography
1
2010
776
0.020
Why?
Mice
1
2023
18261
0.010
Why?
Creatinine
1
2007
509
0.010
Why?
Hospitals, University
1
2005
176
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
990
0.010
Why?
Femur Neck
1
2004
62
0.010
Why?
Bone Diseases, Metabolic
1
2004
58
0.010
Why?
Absorptiometry, Photon
1
2004
276
0.010
Why?
Antibodies, Monoclonal
1
2010
1505
0.010
Why?
Nurses
1
2005
168
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
24
0.010
Why?
Analysis of Variance
1
2004
1301
0.010
Why?
Bone Density
1
2004
484
0.010
Why?
HeLa Cells
1
2002
632
0.010
Why?
Binding Sites
1
2002
1307
0.010
Why?
Clinical Competence
1
2005
1237
0.010
Why?
Physicians
1
2005
949
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)